PureTech Health plc (NASDAQ:PRTC)’s share price shot up 2.7% during trading on Thursday . The stock traded as high as $48.00 and last traded at $48.00. 386 shares were traded during mid-day trading, an increase of 53% from the average session volume of 252 shares. The stock had previously closed at $46.75.
The company has a quick ratio of 2.29, a current ratio of 2.29 and a debt-to-equity ratio of 0.02. The company’s fifty day moving average price is $51.48.
A hedge fund recently bought a new stake in PureTech Health stock. Colony Group LLC bought a new stake in PureTech Health plc (NASDAQ:PRTC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 262,600 shares of the company’s stock, valued at approximately $1,436,000. Colony Group LLC owned about 0.92% of PureTech Health as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 2.08% of the company’s stock.
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and dementia-related psychosis; a hydrogel platform technology to treat obesity and other chronic metabolic diseases; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; a immunomodulation platform to treat chronic and acute inflammatory disorders; therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria; and a digital treatments to treat cognitive dysfunction associated with neurology and psychiatry conditions.
Read More: 52-Week Highs and Lows
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.